Bradley Greg 4
4 · Petros Pharmaceuticals, Inc. · Filed Jan 25, 2023
Insider Transaction Report
Form 4
Bradley Greg
Director
Transactions
- Exercise/Conversion
Common Stock
2023-01-20+2,264→ 2,264 total - Exercise/Conversion
Restricted Stock Units
2023-01-20−2,264→ 0 total→ Common Stock (2,264 underlying)
Footnotes (3)
- [F1]On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split.
- [F2]On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023.
- [F3]Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer.